Effects of matrine and oxymatrine on catalytic activity of cytochrome P450s in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 107, Issue 5, 2010, Pages 906-913

  Yuan, Fang ^a   Chen, Jie ^a   Wu, Wen Jin ^b   Chen, Su Zhen ^a   Wang, Xue Ding ^a   Su, Zeng ^c   Huang, Min ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF MACAU   (Macao)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA NAPHTHOFLAVONE; CONSTITUTIVE ANDROSTANE RECEPTOR; CYTOCHROME P450; CYTOCHROME P450 2B1; CYTOCHROME P450 2B2; CYTOCHROME P450 2E1; CYTOCHROME P450 3A1; DEXAMETHASONE; MATRINE; MESSENGER RNA; OXYMATRINE; PHENOBARBITAL; PREGNANE X RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CATALYSIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

RATTUS; SOPHORA FLAVESCENS;

EID: 78649545898     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2010.00596.x     Document Type: Article

References (37)

1. Tomlinson B, Hu M, Lee VW. In vivo assessment of herb-drug interactions: possible utility of a pharmacogenetic approach? Mol Nutr Food Res 2008;52:799-809.
2. Kim YK, Min BS, Bae KH. A cytotoxic constituent from Sophora flavescens. Arch Pharm Res 1997;20:342-5.
3. Cho CH, Chuang CY, Chen CF. Study of the antipyretic activity of matrine. A lupin alkaloid isolated from Sophora subprostrata. Planta Med 1986;52:343-5.
4. Ling JY, Zhang GY, Cui ZJ, Zhang CK. Supercritical fluid extraction of quinolizidine alkaloids from Sophora flavescens Ait. and purification by high-speed counter-current chromatography. J Chromatogr A 2007;1145:123-7.
5. Wang ML, Zhou QL, Wang BX. Studies on metabolism of oxymatrine by human intestinal bacteria. Zhongguo Zhong Yao Za Zhi 2001;26:272-4.
6. Chen Y, Chen HX, Du P, Han FM. HPLC-electrospray ionization ion trap tandem mass spectrometry analysis of oxymatrine and its metabolites in rat urine. Yao Xue Xue Bao 2005;40:740-5.
7. Zhang MJ, Huang J. Recent research progress of anti-tumor mechanism matrine. Zhongguo Zhong Yao Za Zhi 2004;29:115-8.
8. Liu Y, Zhang XJ, Yang CH, Fan HG. Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression. Brain Res 2009;1268:174-80.
9. Li CQ, Zhu YT, Zhang FX, Fu LC, Li XH, Cheng Y et al. Anti-HBV effect of liposome-encapsulated matrine in vitro and in vivo. World J Gastroenterol 2005;11:426-8.
10. Azzam HS, Goertz C, Fritts M, Jonas WB. Natural products and chronic hepatitis C virus. Liver Int 2007;27:17-25.
11. Ding PL, Huang H, Zhou P, Chen DF. Quinolizidine alkaloids with anti-HBV activity from Sophora tonkinensis. Planta Med 2006;72:854-6.
12. Li J, Li C, Zeng M. Preliminary study on therapeutic effect of oxymatrine in treating patients with chronic hepatitis C. Zhongguo Zhong Xi Yi Jie He Za Zhi 1998;18:227-9.
13. Long Y, Lin XT, Zeng KL, Zhang L. Efficacy of intramuscular matrine in the treatment of chronic hepatitis B. Hepatobiliary Pancreat Dis Int 2004;3:69-72.
14. Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metab Rev 2002;34:83-448.
15. Kobayashi K, Urashima K, Shimada N, Chiba K. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat. Biochem Pharmacol 2002;63:889-96.
16. Lin JH, Lu AY. Inhibition and induction of cytochrome P450 and the clinical implications. Clin Pharmacokinet 1998;35:361-90.
17. Wang H, Faucette S, Sueyoshi T, Moore R, Ferguson S, Negishi M et al. A novel distal enhancer module regulated by pregnane X receptor/constitutive androstane receptor is essential for the maximal induction of CYP2B6 gene expression. J Biol Chem 2003;278:14146-52.
18. Arnold KA, Eichelbaum M, Burk O. Alternative splicing affects the function and tissue-specific expression of the human constitutive androstane receptor. Nucl Recept 2004;2:1-16.
19. Xu M, Yang M, Zheng YF, Zhu HJ, Zhu XQ. Effect of kaempferol on the pharmacokinetics of nifedipine in rats. Zhejiang Da Xue Xue Bao Yi Xue Ban 2006;35:23-8.
20. Mu Y, Zhang J, Zhang S, Zhou HH, Toma D, Ren S et al. Traditional Chinese medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) activate pregnane X receptor and increase warfarin clearance in rats. J Pharmacol Exp Ther 2006;316:1369-77.
21. Zhou S, Paxton JW, Tingle MD, Kestell P. Identification of the human liver cytochrome P450 isoenzyme responsible for the 6-methylhydroxylation of the novel anticancer drug 5, 6-dimethylxanthenone-4-acetic acid. Drug Metab Dispos 2000;28:1449-56.
22. Liu MJ, Wang Z, Li HX, Wu RC, Liu YZ, Wu QY. Mitochondrial dysfunction as an early event in the process of apoptosis induced by woodfordin I in human leukemia K562 cells. Toxicol Appl Pharmacol 2004;194:141-55.
23. Etheridge AS, Black SR, Patel PR, So J, Mathews JM. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Planta Med 2007;73:731-41.
24. He F, Bi HC, Xie ZY, Zuo Z, Li JK, Li X et al. Rapid determination of six metabolites from multiple cytochrome P450 probe substrates in human liver microsome by liquid chromatography/mass spectrometry: application to high-throughput inhibition screening of terpenoids. Rapid Commun Mass Spectrom 2007;21:635-43.
25. Lubet RA, Mayer RT, Cameron JW, Nims RW, Burke MD, Wolff T et al. Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch Biochem Biophys 1985;238:43-8.
26. Qiu F, Zhang R, Sun J, Jiye A, Hao H, Peng Y et al. Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Drug Metab Dispos 2008;36:1308-14.
27. Spiers DE, Candas V. Relationship of skin surface area to body mass in the immature rat: a reexamination. J Appl Physiol 1984;56:240-3.
28. Wu W, Huang J, Liu S, Li X, Cai Y. Study on pharmacokinetics and tissue distribution of stealth matrine liposomes in rats. Zhongguo Zhong Yao Za Zhi 2009;34:751-5.
29. Wang X, Zhang W, Fan LY, Hao B, Ma AN, Cao CX et al. Sensitive quantitative determination of oxymatrine and matrine in rat plasma by capillary electrophoresis with stacking induced by moving reaction boundary. Anal Chim Acta 2007;594:290-6.
30. Chen CX, Liu B, Ma Y, Zhou YJ, Pan XN, Zhen RD et al. Lamivudine, interferon-alpha and oxymatrine treatment for the surviving hepatic failure patients with hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2009;17:505-8.
31. Kalra BS. Cytochrome P450 enzyme isoforms and their therapeutic implications: an update. Indian J Med Sci 2007;61:102-16.
32. Ueng YF, Chen CC, Tsai CC, Soucek P. Differential inductive profiles of hepatic cytochrome P450s by the extracts of Sophora flavescens in male and female C57BL/6JNarl mice. J Ethnopharmacol 2009;126:437-46.
33. Zanger UM, Turpeinen M, Klein K, Schwab M. Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem 2008;392:1093-108.
34. Turpeinen M, Raunio H, Pelkonen O. The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico. Curr Drug Metab 2006;7:705-14.
35. Yuan C, Lu SQ, Yao X. Effects of oxymatrine on the antitumor activity and toxicity of cyclophosphamide in mice. Yao Xue Xue Bao 1987;22:245-9.
36. Xie W, Evans RM. Orphan nuclear receptors: the exotics of xenobiotics. J Biol Chem 2001;276:37739-42.
37. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB et al. Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 2000;275:15122-7.